Lightbridge Corporation Reports 177% Revenue Increase but Faces $19.6 Million Net Loss for Fiscal Year 2025

Lightbridge Corporation reported a significant increase in its financial performance for the fiscal year ending December 31, 2025, with total revenues reaching $3.6 million, compared to $1.3 million in 2024, marking a 177% increase. However, the company also experienced a net loss of $19.6 million, a 66% increase from the previous year's loss of $11.8 million. The rise in operating expenses, which totaled $23.2 million, was primarily driven by a 65% increase in general and administrative costs and a 100% increase in research and development expenses, reflecting the company's ongoing investment in its nuclear fuel technology.

In terms of strategic developments, Lightbridge has made notable progress in its partnerships and agreements. The company signed a Memorandum of Understanding with Oklo, Inc. to explore the feasibility of co-locating a commercial-scale fuel fabrication facility. Additionally, a Master Services Agreement with Amentum Technology Inc. was established to support this initiative. Lightbridge also entered into collaborative agreements for the development of cladding alloy compositions and initiated irradiation testing of its fuel material coupon samples at the Idaho National Laboratory (INL), which is expected to provide critical data for future commercialization efforts.

Operationally, Lightbridge's workforce remained stable, with 13 full-time employees as of December 31, 2025. The company is focused on advancing its Lightbridge Fuel™ technology, which aims to enhance the economics and safety of nuclear power generation. The anticipated commercialization timeline for the technology is projected to begin in the mid-2030s, with initial fuel reload orders expected in the late 2030s. The company is actively working to secure additional funding and partnerships to support its research and development activities, which are crucial for meeting its long-term goals.

Lightbridge's financial outlook remains cautious, as the company acknowledges the need for significant additional capital to fund its operations and R&D activities. As of December 31, 2025, the company had cash and cash equivalents of $201.9 million, a substantial increase from $40 million in 2024, primarily due to successful equity offerings. However, the company anticipates that its existing capital resources will not be sufficient to sustain operations beyond the next 12 months without further financing. The management is exploring various funding avenues, including public or private equity offerings and potential government grants, to ensure the continued development of its nuclear fuel technology.